Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret Stock

Equities

ANGEN

TREANGN00028

Biotechnology & Medical Research

Market Closed - Borsa Istanbul 11:09:52 2024-05-24 am EDT 5-day change 1st Jan Change
12.57 TRY -1.72% Intraday chart for Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret -4.70% +0.96%
Sales 2021 410M 12.74M Sales 2022 269M 8.35M Capitalization 4.74B 147M
Net income 2021 433M 13.45M Net income 2022 330M 10.25M EV / Sales 2021 6.59 x
Net cash position 2021 511M 15.86M Net cash position 2022 411M 12.77M EV / Sales 2022 16.1 x
P/E ratio 2021
5.1 x
P/E ratio 2022
14.3 x
Employees 171
Yield 2021 *
-
Yield 2022
2.76%
Free-Float 25.33%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.72%
1 week-4.70%
Current month-5.35%
1 month-11.23%
3 months-9.70%
6 months-9.63%
Current year+0.96%
More quotes
1 week
12.26
Extreme 12.26
13.60
1 month
12.26
Extreme 12.26
14.72
Current year
12.02
Extreme 12.02
14.93
1 year
10.62
Extreme 10.62
21.76
3 years
9.23
Extreme 9.23
25.03
5 years
9.23
Extreme 9.23
25.03
10 years
9.23
Extreme 9.23
25.03
More quotes
Managers TitleAgeSince
Founder 49 10-06-10
Chief Executive Officer 54 10-06-10
Director of Finance/CFO 37 20-11-30
Members of the board TitleAgeSince
Chief Executive Officer 54 10-06-10
Founder 49 10-06-10
Director of Finance/CFO 37 20-11-30
More insiders
Date Price Change Volume
24-05-24 12.57 -1.72% 1,804,230
24-05-23 12.79 -1.92% 2,016,187
24-05-22 13.04 +2.44% 2,053,886
24-05-21 12.73 -5.49% 3,581,341
24-05-20 13.47 +2.12% 2,414,510

Delayed Quote Borsa Istanbul, May 24, 2024 at 11:09 am EDT

More quotes
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS is a Turkey-based company, which is s a biotechnology company operating in accordance with ISO 9001, ISO 13485 and 98/79/EC Total Quality Systems. The Company's main activities are to develop and produce Real-Time Polymerase Chain Reaction (Real-Time PCR) kits, and to create a complete solution with automatic nucleic acid isolation devices and Real-Time PCR Systems. The main goals of the entity are to reduce Turkey's foreign dependency in molecular diagnostics and biotechnology and to gain success in the global market by developing and producing molecular genetic products.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
12.57 TRY
Average target price
15.4 TRY
Spread / Average Target
+22.51%
Consensus